Home >> Report Store >> Healthcare >> Pharmerging Market Size & Share – Global Forecast to 2025 >

Pharmerging Market Size Worth $2.1 Trillion By 2025 | CAGR: 15.7%

Published Date : 19 / 07 / 18  | Report Format: PDF

The global Pharmerging market is expected to grow at growth rate of 15.7% to reach USD 2,106.9 billion by 2025.

The pharmerging industry covers the study for developing countries where the use of pharmaceuticals is rapidly growing and is projected to experience strong growth in the future period. Countries such as China, India, Brazil, Russia, and South Africa among others are considered under the research scope. Drug spending in these economies is increasing at a constant rate, making them attractive targets for drug manufacturers to invest in. For example, the Chinese government is planning to spend over USD 120 billion for healthcare services for its 1.3 billion population over the next 10 years. Also, economies such as India, Brazil, and Russia are constructing and upgrading new hospitals in urban centers to cater to unmet medical needs. These facts would, in turn, boost the spending on healthcare services, establishing the healthy platform for the industry growth.

There is a constant rise of people affected by chronic disorders due to the lifestyle changes. The number of cardiovascular, cancer, respiratory and diabetes patients are increasing monumentally. For example, cardiovascular conditions such as strokes, coronary heart disease, rheumatic heart disease, and cardiomyopathy are expected to be the major causes of mortality and morbidity in developing countries across the world. As per the World Health Organization statistics, more than 80% of cardiovascular deaths occur in low to middle-income countries.  Additionally, an aging population, higher standards of living and advancement in technologies in the medical sector have led to a sharp increase in life expectancy. As a consequence, longer-lived individuals will create upward pressure on demand for pharmaceuticals & healthcare services.

Key Takeaways

  • Product types comprise of Pharmaceuticals and Healthcare. Of these, pharmaceuticals accounted for the highest share in terms of value. However, it is analyzed that healthcare products are anticipated to grow with lucrative growth rate.
  • In 2017, generic pharmaceuticals recorded USD 198.7 billion and the segment is projected to grow with strong CAGR during the future period
  • Among the different economies considered, China (Tier I) has captured major revenue share (over 52% of the worldwide market) owing to the rising chronic disease incidences, large patient pool, and increasing demand for medical services.
  • Drug spending in China is majorly focused on non-branded generic therapeutics which is projected grow at double the rate of branded therapeutics. According to China’s Ministry of Finance (MOF), healthcare expenditure in the country has increased by 10% in 2016.
  • Tier II category include a detailed study for BRICS countries (except China) such as India, Russia, Brazil and South Africa. India and Brazil collectively accounted for over 60% revenue share of the countries considered under Tier II economy.
  • Tier III includes extensive qualitative and quantitative study for Turkey, Poland, Mexico, Argentina, Thailand, and Saudi Arabia.
  • Companies namely Pfizer, Inc., AstraZeneca, Roche, GE Healthcare, and Medtronic are actively operating in this industry. These companies are increasingly investing in research and development activities to develop new products.
  • In a meantime, growing demand for effective pharmaceuticals in pharmerging economies could be boon for generic therapeutic-focused companies like Teva Pharma, Abbvie, & Mylan

KEY BENEFITS OF THE REPORT:

  • In-depth analysis of the key market dynamics
  • Granular analysis of the current market scenario and expected factors to affect the market
  • Detailed analysis of the geographic region, regional and county wise analysis
  • Highlight on the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the market

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

MARKET, BY PRODUCT TYPES

  • Pharmaceuticals
    • Patented
    • Generic
    • Over-the-Counter
  • Healthcare
    • Medical Devices
    • In-Vitro Diagnostics
    • Others

MARKET, BY REGION

  • Tier I
    • China
  • Tier II
    • India
    • Russia
    • Brazil
    • South Africa
  • Tier III
    • Turkey
    • Poland
    • Mexico
    • Argentina
    • Thailand
    • Saudi Arabia

Why AnalystView

 

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

 

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

 

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This